From 2000

Evolving into an integrated health and beauty care company

2001年
(平成13年)

Launched cosmetics brand "Obagi".

It sparked a vitamin C boom.

2002年
(平成14年)

Launched "Rohto Eye Stretch".

Acquired MG Pharma Co., Ltd.

2003年
(平成15年)

The second factory building (skin care product factory) was completed in the Ueno Techno Center.

Launched Mentholatum Medi Quick.

2004年
(平成16年)

Launched basic skincare brand "Hada-labo."

A new symbol mark and slogan were established.

2005年
(平成17年)

Launched "Mentholatum Melano Buster (now MELANO CC)".

2006年
(平成18年)

Rohto Research Village Kyoto research center opens

Launched "OXY" as a men's skincare brand in Japan.

Launched "Wakan-sen".

2007年
(平成19年)

Acquired Meguro Kako Co., Ltd. (now Qualitech Pharma Co., Ltd., a consolidated subsidiary) and gained management rights.

Launched "50 Megumi".

2008年
(平成20年)

Tokyo branch office moves to new building.

Launched sunscreen "SKIN AQUA".

2009年
(平成21年)

Kunio Yamada becomes chairman and Toshiaki Yoshino becomes president.

Launched "Epistem".

Entered the department store sector.

2010年
(平成22年)

Tianjin Rohto Herbal Medicine Co., Ltd. (currently a consolidated subsidiary) is established in China.

2011年
(平成23年)

A new "Disaster Reconstruction Support Office" has been established to support orphans of the earthquake disaster.

2013年
(平成25年)

Launched "De-O".

Shunkoku Shunsai opens in Grand Front Osaka (closed in May 2022).

Changed to "Regenerative medicine Research Planning Department, Agri-Farm Business Department."

The Grand Front Osaka office was opened in the Grand Front Osaka shopping mall in front of Osaka Station, and some of the head office functions were relocated there.

2015年
(平成27年)

Launched ROHTO V5 tablets.

Acquired shares of Mayado Pharmaceutical Co., Ltd. (making it a subsidiary).

2016年
(平成28年)

New CI “NEVER SAY NEVER” established.

Started double job within the company and challenge work outside the company.

Acquired shares in A.J. North (Pty) Ltd, in the Republic of South Africa (making it a subsidiary).

Acquired shares in OPHTHALMOS S.A., a Brazilian eye drop manufacturing and sales company (making it a subsidiary).

The Rohto Stem Cell Processing Center (now Cell Factory Kyoto) within Rohto Research Village Kyoto obtained a "Specific Cell Processing Product Manufacturing License".

Launched "Rohto V Premium", the first of the high-priced eye drops "V Rohto Series."

2017年
(平成29年)

June 10th has been designated as Rohto Day, as certified by the Japan Anniversary Association.

Japan's first clinical trial begins for allogeneic adipose tissue-derived stem cell preparation ADR-001 for liver cirrhosis.

2018年
(平成30年)

Launched "DEOCO".

2019年
(平成31年)

We have introduced the health coin "ARUCO to support employee health promotion.

Masashi Sugimoto becomes president.

2020年
(令和2年)

We acquired Nippon Eye Drop Research Institute Co., Ltd. (now ROHTO NITTEN Co., Ltd., a consolidated subsidiary) and gained control of its management.

A "COVID-19 Medical Institution Support Office" has been established.

Announced the launch of a Japan-made, first-of-its-kind corporate clinical trial of Regenerative medicine using allogeneic mesenchymal stem cells for severe COVID-19 pneumonia.

2021年
(令和3年)

Acquired shares of  Olympus RMS Co., Ltd.  (currently Interstem Co., Ltd., a consolidated subsidiary).

Obtained manufacturing and sales approval and launched a rapid antigen test kit for the novel coronavirus (SARS-CoV-2).

Rohto Pharmaceutical Co., Ltd. acquires shares in Amato Pharmaceutical Products, Ltd. (making it a subsidiary).

2022年
(令和4年)

New factory building C at Ueno Techno Center completed.

2023年
(令和5年)

Participated in the Fujita Health University Tokyo Advanced Medical Research Center, a next-generation medical and research hub.

2024年
(令和6年)

A laboratory and office was opened at Nakanoshima Qross (International Center for Future Medicine).

Acquired shares in Eu Yan Sang International Ltd., a Singaporean herbal medicine manufacturer and distributor.

Acquired shares in the Austrian pharmaceutical company Mono chem-pharm Produkte GmbH.

2025年
(令和7年)

Participated in the Osaka Healthcare Pavilion at the 2015 World Exposition in Osaka, Japan (Osaka-Kansai Expo).

Hidetoshi Seki becomes president.